This Monday at 10:00 Pm on TV One, “Payback” Season 2 Episode 12, titled “I’m Not Scared,” presents a riveting story of justice and revenge. The episode unfolds two months after a man is acquitted of a murder charge, only to tragically become a victim of gun violence. The police are quick to suspect that the shooting is an act of revenge, sending shockwaves through both law enforcement and the community.
As the narrative intensifies, a startling revelation comes to light— the victim’s own cousin played a role in luring him to his untimely demise. The twist adds layers of complexity to the investigation, prompting questions about family loyalty and the intricate web of motives behind the act.
Tune in at 10:00 Pm for an episode that delves into the aftermath of a legal verdict and the consequences that follow, highlighting the blurred lines between justice and personal vendettas. “Payback” on...
As the narrative intensifies, a startling revelation comes to light— the victim’s own cousin played a role in luring him to his untimely demise. The twist adds layers of complexity to the investigation, prompting questions about family loyalty and the intricate web of motives behind the act.
Tune in at 10:00 Pm for an episode that delves into the aftermath of a legal verdict and the consequences that follow, highlighting the blurred lines between justice and personal vendettas. “Payback” on...
- 12/4/2023
- by Jules Byrd
- TV Everyday
New York, Sep 6 (Ians) Tracking eye movements in toddlers can help gauge the risk of autism years before symptoms appear and diagnosis is made, accelerating treatment, according to two studies.
Results of clinical studies published simultaneously in the Journal of the American Medical Association (Jama) and in Jama Network Open demonstrate that measuring children’s looking behaviour predicts expert clinical diagnosis of autism in about 1,500 children between ages 16 to 30 months tested with a high degree of accuracy.
Researchers from Marcus Autism Center, a subsidiary of Children’s Healthcare of Atlanta, US, have also developed a technology to reliably measure how children with autism look at and learn from their surrounding social environment.
In addition, the technology measures each child’s individual levels of social disability, verbal ability and non-verbal learning ability, which is critical information for clinicians when developing personalised treatment plans to help each child make the greatest gains.
Results of clinical studies published simultaneously in the Journal of the American Medical Association (Jama) and in Jama Network Open demonstrate that measuring children’s looking behaviour predicts expert clinical diagnosis of autism in about 1,500 children between ages 16 to 30 months tested with a high degree of accuracy.
Researchers from Marcus Autism Center, a subsidiary of Children’s Healthcare of Atlanta, US, have also developed a technology to reliably measure how children with autism look at and learn from their surrounding social environment.
In addition, the technology measures each child’s individual levels of social disability, verbal ability and non-verbal learning ability, which is critical information for clinicians when developing personalised treatment plans to help each child make the greatest gains.
- 9/6/2023
- by Agency News Desk
- GlamSham
Sydney, Aug 29 (Ians) A new drug offers a breakthrough world first treatment for Lipoprotein(a) — a largely genetic form of ‘sticky’ cholesterol that increases the risk of deadly heart attack and stroke, according to a study.
High levels of Lipoprotein(a), is similar to Ldl cholesterol, sometimes called ‘bad cholesterol’, but is more sticky, increasing risk of blockages and blood clots in arteries. It impacts one in five people globally with no approved treatment currently on the market.
The first human trial led by Monash University in Australia demonstrated the success of Muvalaplin.
The first oral drug ever developed to target Lp(a) effectively lowered its levels by up to 65 per cent. It works by disrupting the ability for Lp(a) to form in the body.
The findings were presented at the European Society of Cardiology Congress in Amsterdam and also published in Jama.
“This drug is a gamechanger in more ways than one.
High levels of Lipoprotein(a), is similar to Ldl cholesterol, sometimes called ‘bad cholesterol’, but is more sticky, increasing risk of blockages and blood clots in arteries. It impacts one in five people globally with no approved treatment currently on the market.
The first human trial led by Monash University in Australia demonstrated the success of Muvalaplin.
The first oral drug ever developed to target Lp(a) effectively lowered its levels by up to 65 per cent. It works by disrupting the ability for Lp(a) to form in the body.
The findings were presented at the European Society of Cardiology Congress in Amsterdam and also published in Jama.
“This drug is a gamechanger in more ways than one.
- 8/29/2023
- by Agency News Desk
- GlamSham
New York, June 8 (Ians) The recently approved antiviral Letermovir for the treatment of cytomegalovirus infections (Cmv) has also shown promise for kidney transplant patients, who are more susceptible to the virus, according to results of a phase-iii clinical trial.
Cmv is a common virus that infects people of all ages and spreads through body fluids. It usually remains dormant, causing no symptoms or a mild illness characterised by fever, sore throat, fatigue, or swollen glands.
But in people with impaired immune systems, such as transplant recipients, Cmv can produce serious symptoms affecting the eyes, lungs, oesophagus, intestines, stomach, or liver.
Letermovir, developed by US drug major Merck, has shown similar efficacy to valganciclovir in preventing Cmv disease in recipients of kidneys from Cmv-positive donors.
Letermovir also causes less propensity to cause low counts of infection-fighting white blood cells, according to the results, published in the Journal of the American Medical...
Cmv is a common virus that infects people of all ages and spreads through body fluids. It usually remains dormant, causing no symptoms or a mild illness characterised by fever, sore throat, fatigue, or swollen glands.
But in people with impaired immune systems, such as transplant recipients, Cmv can produce serious symptoms affecting the eyes, lungs, oesophagus, intestines, stomach, or liver.
Letermovir, developed by US drug major Merck, has shown similar efficacy to valganciclovir in preventing Cmv disease in recipients of kidneys from Cmv-positive donors.
Letermovir also causes less propensity to cause low counts of infection-fighting white blood cells, according to the results, published in the Journal of the American Medical...
- 6/8/2023
- by Agency News Desk
- GlamSham
Oscar-winning director Gabriele Salvatores (“Mediterraneo”) is back behind the camera on “Napoli – New York,” a period immigration drama based on a story written for the screen by Federico Fellini.
Fellini co-wrote the tale of two Neapolitan kids who embark on a ship to New York to escape Italy’s early postwar poverty with his frequent collaborator Tullio Pinelli, a writer on the Italian maestro’s “La Dolce Vita” and “8 1/2,” as well as other titles.
Italian A-lister Pierfrancesco Favino stars as the chief officer of the ship which the two kids, named Carmine and Celestina, manage to board surreptitiously in the port of Naples, becoming clandestine passengers. The youngsters are on a mission to reach the U.S. where they dream of living with Celestina’s sister, who emigrated to New York two years earlier. Newcomers Dea Lanzaro e Antonio Guerra play the kids. (See first-look image above of Favino with the kids and Salvatores.
Fellini co-wrote the tale of two Neapolitan kids who embark on a ship to New York to escape Italy’s early postwar poverty with his frequent collaborator Tullio Pinelli, a writer on the Italian maestro’s “La Dolce Vita” and “8 1/2,” as well as other titles.
Italian A-lister Pierfrancesco Favino stars as the chief officer of the ship which the two kids, named Carmine and Celestina, manage to board surreptitiously in the port of Naples, becoming clandestine passengers. The youngsters are on a mission to reach the U.S. where they dream of living with Celestina’s sister, who emigrated to New York two years earlier. Newcomers Dea Lanzaro e Antonio Guerra play the kids. (See first-look image above of Favino with the kids and Salvatores.
- 6/5/2023
- by Nick Vivarelli
- Variety Film + TV
New York, Feb 25 (Ians) Long-term exposure to air pollution, particularly particulate matter (Pm) 2.5, has been linked with an increased risk of heart attack and other cardiovascular diseases, according to a new study.
In a diverse cohort of 3.7 million adults in California, the study published in Jama Network Open found that long-term Pm 2.5 exposure was associated with an increased risk of incident acute myocardial infarction (Ami), ischemic heart disease mortality, and cardiovascular disease mortality.
These associations were more pronounced in low socioeconomic status communities.
The results add to the growing evidence that long-term Pm 2.5 exposure is associated with increased risk of cardiovascular events and current regulatory standards of Pm 2.5 are not sufficiently protective.
The retrospective cohort study included adults in the Kaiser Permanente Northern California integrated health care system during 2007 to 2016 and followed for up to 10 years. The participants had no prior stroke or acute myocardial infarction (Ami).
Fine particulate air...
In a diverse cohort of 3.7 million adults in California, the study published in Jama Network Open found that long-term Pm 2.5 exposure was associated with an increased risk of incident acute myocardial infarction (Ami), ischemic heart disease mortality, and cardiovascular disease mortality.
These associations were more pronounced in low socioeconomic status communities.
The results add to the growing evidence that long-term Pm 2.5 exposure is associated with increased risk of cardiovascular events and current regulatory standards of Pm 2.5 are not sufficiently protective.
The retrospective cohort study included adults in the Kaiser Permanente Northern California integrated health care system during 2007 to 2016 and followed for up to 10 years. The participants had no prior stroke or acute myocardial infarction (Ami).
Fine particulate air...
- 2/25/2023
- by News Bureau
- GlamSham
New York, Aug 28 (Ians) The antiviral tecovirimat appears to be safe and effective for the treatment of monkeypox symptoms and skin lesions, finds a new study.
Tecovirimat (Tpoxx) is an Fda-approved antiviral drug for the treatment of smallpox. It limits viral spread in the body by inhibiting the work of the protein involved in releasing the enveloped virus.
“We have very limited clinical data on the use of tecovirimat for monkeypox infection. There is much to learn about the natural progression of the disease and how tecovirimat and other antivirals may affect it,” said lead author Angel Desai from the University of California, Davis.
The recent global outbreak of monkeypox has led to more than 45,500 cases as of August 22, 2022. While symptoms usually resolve on their own in 2-4 weeks, a recent study showed that 13 per cent of patients needed hospitalisation.
For the new study, published in the journal Jama,...
Tecovirimat (Tpoxx) is an Fda-approved antiviral drug for the treatment of smallpox. It limits viral spread in the body by inhibiting the work of the protein involved in releasing the enveloped virus.
“We have very limited clinical data on the use of tecovirimat for monkeypox infection. There is much to learn about the natural progression of the disease and how tecovirimat and other antivirals may affect it,” said lead author Angel Desai from the University of California, Davis.
The recent global outbreak of monkeypox has led to more than 45,500 cases as of August 22, 2022. While symptoms usually resolve on their own in 2-4 weeks, a recent study showed that 13 per cent of patients needed hospitalisation.
For the new study, published in the journal Jama,...
- 8/28/2022
- by Glamsham Bureau
- GlamSham
Taylor Swift is bringing her short film “All Too Well” to the 2022 Tribeca Festival.
Swift will make a rare appearance to host a special screening of “All Too Well: The Short Film,” which she wrote, produced and directed as part of her “Red” album re-release. The screening, which will take place on June 11 at the Beacon Theatre, will be followed by a conversation with Swift about her approach as a filmmaker.
Pharrell Williams, Seth Meyers, Steve Aoki and Cynthia Erivo, as well as directors Tyler Perry, Adam McKay and Julian Schnabel will also participate in Tribeca’s talks series.
In addition to special talks, Tribeca is organizing film reunions, and master classes with intimacy coordinators, music supervisors and more. The reunion lineup includes Robert De Niro and Al Pacino discussing “Heat,” as well as members of the cast and crew of films “Eve’s Bayou” and “Velvet Goldmine” as they both celebrate their 25th anniversaries.
Swift will make a rare appearance to host a special screening of “All Too Well: The Short Film,” which she wrote, produced and directed as part of her “Red” album re-release. The screening, which will take place on June 11 at the Beacon Theatre, will be followed by a conversation with Swift about her approach as a filmmaker.
Pharrell Williams, Seth Meyers, Steve Aoki and Cynthia Erivo, as well as directors Tyler Perry, Adam McKay and Julian Schnabel will also participate in Tribeca’s talks series.
In addition to special talks, Tribeca is organizing film reunions, and master classes with intimacy coordinators, music supervisors and more. The reunion lineup includes Robert De Niro and Al Pacino discussing “Heat,” as well as members of the cast and crew of films “Eve’s Bayou” and “Velvet Goldmine” as they both celebrate their 25th anniversaries.
- 5/2/2022
- by Rebecca Rubin
- Variety Film + TV
The Emmy Award-winning television host, comedian and writer Seth Meyers, best known for hosting Late Night with Seth Meyers and as the former head writer of Saturday Night Live, can now add New York Times bestselling children’s book author to his resume.
Late-night host Seth Meyers reads his new children's book for Storyline Online
The quick-witted Meyers recently offered his many talents to the SAG-AFTRA Foundation's Storyline Online with a read-aloud of his first publication I’m Not Scared, You’Re Scared! — a hilarious picture book about a fearless rabbit and fearful bear who learn the true meaning of bravery throughout the rollicking story.
With illustrations by Rob Sayegh Jr., I’m Not Scared, You’Re Scared! is a story filled with themes of friendship, adventure, and bravery, and features a daring rescue that will inspire young readers to face their fears together. Meyers’ debut children’s book...
Late-night host Seth Meyers reads his new children's book for Storyline Online
The quick-witted Meyers recently offered his many talents to the SAG-AFTRA Foundation's Storyline Online with a read-aloud of his first publication I’m Not Scared, You’Re Scared! — a hilarious picture book about a fearless rabbit and fearful bear who learn the true meaning of bravery throughout the rollicking story.
With illustrations by Rob Sayegh Jr., I’m Not Scared, You’Re Scared! is a story filled with themes of friendship, adventure, and bravery, and features a daring rescue that will inspire young readers to face their fears together. Meyers’ debut children’s book...
- 4/19/2022
- Look to the Stars
Disney+ has snatched up new Italian drama series Anna for much of Europe, inking a deal with Fremantle to launch the show from award-winning writer-director Niccolò Ammaniti (The Miracle, I’m Not Scared) on its streaming service in various countries, including the U.K. and Ireland, France, Spain, Portugal, Germany and across the Nordic territories.
Fremantle, whose Italian company Wildside (The Young Pope) produced Anna as a Sky original together with Arte France, has closed deals for more than 30 territories for the series, from Poland (Canal+) to Russia and Cis (Amedia TV), from Korea (Watcha) to French-speaking Canada (Videotron).
Anna, which Ammaniti adapted from ...
Fremantle, whose Italian company Wildside (The Young Pope) produced Anna as a Sky original together with Arte France, has closed deals for more than 30 territories for the series, from Poland (Canal+) to Russia and Cis (Amedia TV), from Korea (Watcha) to French-speaking Canada (Videotron).
Anna, which Ammaniti adapted from ...
- 11/12/2021
- The Hollywood Reporter - Film + TV
Disney+ has snatched up new Italian drama series Anna for much of Europe, inking a deal with Fremantle to launch the show from award-winning writer-director Niccolò Ammaniti (The Miracle, I’m Not Scared) on its streaming service in various countries, including the U.K. and Ireland, France, Spain, Portugal, Germany and across the Nordic territories.
Fremantle, whose Italian company Wildside (The Young Pope) produced Anna as a Sky original together with Arte France, has closed deals for more than 30 territories for the series, from Poland (Canal+) to Russia and Cis (Amedia TV), from Korea (Watcha) to French-speaking Canada (Videotron).
Anna, which Ammaniti adapted from ...
Fremantle, whose Italian company Wildside (The Young Pope) produced Anna as a Sky original together with Arte France, has closed deals for more than 30 territories for the series, from Poland (Canal+) to Russia and Cis (Amedia TV), from Korea (Watcha) to French-speaking Canada (Videotron).
Anna, which Ammaniti adapted from ...
- 11/12/2021
- The Hollywood Reporter - Movie News
This column is a collaboration with DoubleBlind, a print magazine and media company at the forefront of the psychedelic movement.
This fall, the federal government granted researchers funding to study the therapeutic potential of a classic psychedelic for the first time in 50 years. The National Institutes of Health granted Johns Hopkins Medicine, in collaboration with University of Alabama at Birmingham and New York University, $4 million to investigate if psilocybin — one of the primary psychoactive ingredients in psychedelic mushrooms — can help people quit smoking.
“This is a huge step for really...
This fall, the federal government granted researchers funding to study the therapeutic potential of a classic psychedelic for the first time in 50 years. The National Institutes of Health granted Johns Hopkins Medicine, in collaboration with University of Alabama at Birmingham and New York University, $4 million to investigate if psilocybin — one of the primary psychoactive ingredients in psychedelic mushrooms — can help people quit smoking.
“This is a huge step for really...
- 11/11/2021
- by Shelby Hartman and Madison Margolin
- Rollingstone.com
Michael Schultz's Woman Thou Art Loosed was named best American film -- winning the American Spirit Award, which included a $30,000 camera package from Panavision -- at the 19th annual Santa Barbara International Film Festival, which concluded its 10-day run Sunday. The best documentary prize went to George Hickenlooper's Mayor of the Sunset Strip, and the foreign film prize was awarded to I'm Not Scared, directed by Gabriele Salvatores. The festival drew 51,000 filmgoers and screened more than 150 films. The program also included tributes to Peter Jackson, who received the Modern Master Award; Charlize Theron, cited for Outstanding Performance of the Year for her work in Monster; and Diane Lane, presented with the inaugural Riviera Award for her film career. "This festival has been a whirlwind since opening night," SBIFF artistic director Roger Durling said. "It has been an amazing experience."...
IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news articles, Tweets, and blog posts do not represent IMDb's opinions nor can we guarantee that the reporting therein is completely factual. Please visit the source responsible for the item in question to report any concerns you may have regarding content or accuracy.